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Objective: To determine whether patients with Alz-
heimer's disease (AD) who do not have historical or
clinical evidence of stroke but who do have computed
tomographic or magnetic resonance imaging evidence
of noncortical lesions smaller than 2 cm or periven-
tricular "caps" differ from other patients with AD.
Methods: The computed tomographic or magnetic
resonance imaging scans of 158 patients meeting crite-
ria of the National Institute of Neurological Disorders
and Stroke\p=m-\Alzheimer'sDisease and Related Disorders
Association for probable AD were reviewed by one
neuroradiologist. Two measures of disease severity\p=m-\
the Modified Mini-Mental State examination and the
Blessed Dementia Rating Scale (Part I)\p=m-\weresub-
jected to two-way analysis of variance with scan type(computed tomography or magnetic resonance imag-
ing) and lesion number as between-group factors and
age and disease duration as covariates.
Results: No relationship was seen between lesion num-
ber or periventricular caps and disease severity.
Conclusion: In this cross-sectional analysis using
these clinical measures, patients with AD who have
well-defined radiographic abnormalities cannot be dif-
ferentiated from patients with AD who do not have
them.
(Arch Neurol. 1995;52:146-151)
Clinical and research cri¬teria for probable Alz¬heimer's disease (AD)1·2have traditionally ex¬cluded patients with his¬
torical or radiographie evidence of stroke.
With the advent of magnetic resonance im¬
aging (MRI), the sensitivity of detection
of vascular disease has increased. Al¬
though the pathologic basis of both peri¬
ventricular white matter lesions and fo¬
cal lesions distinct from the ventricles
remains controversial,3 these lesions have
been found to correlate with increasing age
and vascular risk factors. They are seen in
both demented and nondemented indi¬
viduals and have been termed leukoara¬
iosis* Despite the apparent lack of speci¬
ficity of both types of lesions, patients
meeting criteria for AD who have these le¬
sions on CT or MRI have been excluded
from clinical trials for AD. Our objective
was to determine whether patients with AD
without historical or clinical evidence of
stroke who nonetheless had CT or MRI
evidence of focal lesions distinct from the
ventricles, periventricular white matter le¬
sions, or periventricular "caps" differed
from patients with AD who did not have
them. If there is little or no distinction be¬
tween these two qroups of patients, they
should be considered to have probable AD2
and be included in future observational
studies and experimental trials.
RESULTS
DEMOGRAPHIC CHARACTERISTICS
OF PATIENTS WITH AND
WITHOUT SCANS
The 158 patients who had their scans re¬
viewed by the study neuroradiologist Q.B.)
were contrasted with the 66 patients who
had only scan reports available for re¬
view to determine whether there was a se¬
lection bias within the study. The two
groups did not significantly differ in age,
education, systolic or diastolic blood pres¬
sure, history of hypertersion, estimated du¬
ration of illness, and mMMSE, BDRS-I, or
Hachinski Ischemie scores.
See Patients and Methods
on next page
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PATIENTS AND METHODS
SUBJECT SELECTION
All subjects were participants in the Predictors Study, a mul-
ticenter longitudinal study of predictors of disease course in
AD. A total of 224 patients (91 from Columbia University, New
York, NY, 76 fromJohns Hopkins University School ofMedi¬
cine, Baltimore, Md, and 57 from the Massachusetts General
Hospital, Boston) gave informed consent and underwent a base¬
line evaluation. Patients were recruited primarily from out¬
patient facilities specializing in the care of patients with AD
at all three sites. Details of recruitment strategy, study design,
and intersite comparisons have been previously described.5
PATIENT INCLUSION CRITERIA
All patients, with the exception of those with CT or MRI
abnormalities, met National Institute of Neurological Dis¬
orders and Stroke-Alzheimer's Disease and Related Disor¬
ders Association criteria for probable AD. To ensure that
patients with relatively mild AD were recruited, all had a
Modified Mini-Mental State examination (mMMSE)6 score
of 30 or more (equivalent to a MMSE score7 of a 13) at study
entry. Only patients fluent in English were included. All
patients had a responsible caregiver who agreed to serve
as a patient advocate throughout the 5-year study. Disease
duration was estimated by the physician, based on the in¬
terview of the patient and informant.
PATIENT EXCLUSION CRITERIA
Patients who met National Institute of Neurological Dis¬
orders and Stroke-Alzheimer's Disease and Related Disor¬
ders Association criteria for possible AD, eg, patients with
concurrent hypothyroidism or vitamin B12 deficiency, were
not included. In addition, patients who had a history of
schizophrenia or schizoaffective disorder, who had under¬
gone electroconvulsive therapy within 2 years of recruit¬
ment, or who met the criteria of the Diagnostic and Statis¬
tical Manual oj Mental Disorders, Revised Third Edition, for
alcohol abuse or dependency were excluded.1
RADIOGRAPHIC EVALUATION
This study was not designed to assess radiographie corre¬
lates of AD. Rather, radiologie studies were used primarily
to exclude other causes of dementia such as neoplasm, sub¬
dural hematoma, or vascular disease. Although all sub¬jects underwent either CT or MRI as part of their evalua¬
tion, there was no specific imaging protocol. The decision
on the type of imaging study performed was made clini¬
cally by the evaluating physician, who was not always an
investigator in the study. For the present analysis, all pa¬
tients were requested to obtain their radiologie studies (CT
or MRI) for review by the study neuroradiologist at Co¬
lumbia University (J-B.). Only scans reviewed by the study
radiologist were included to ensure standardized review.
All films were systematically reviewed for the pres¬
ence of atrophy, using criteria modeled after the Consor¬
tium to Establish a Registry for Alzheimer's Disease,8 in
which patient age was considered in the final judgment of
atrophy. Focal atrophy, if located particularly within a vas¬
cular distribution, was considered indicative of possible prior
stroke and was grounds for study exclusion. Subjects who
had cortical lesions, even if there was no clinical evidence
of stroke, were not entered into the longitudinal study be¬
cause of the greater likelihood that their lesions might con¬
tribute more to cognitive impairment than other lesions.
In addition, lesions that were 2 cm or larger and/or seen
on more than two contiguous images on MRI or on more




Very few patients were excluded from the longitudinal
study based on radiographie findings of clinically silent
cortical infarcts or other noncortical large lesions. Six pa¬
tients were rejected on this basis at Columbia Univer¬
sity, two at Massachussetts General Hospital, and one at
Johns Hopkins University School of Medicine.
TEST-RETEST RELIABLITY
FOR LESIONS AND CAPS
Fifteen random scans (six CT and nine MRI) were re¬
viewed a second time by the study neuroradiologist. This
review was done with the rater blind to the fact that the
scans had already been reviewed. The observed agree¬
ment for the presence and severity of lesions was high(80%). When corrected for chance agreement, reliabil¬
ity was in the fair-to-good range" ( coefficient, 0.49).
The observed agreement for the presence or absence of
periventricular caps was also very high (87%). When cor-
rected for chance agreement, the  coefficient was 0.59,
again in the fair-to-good range.
REFERRAL FOR MRI VS CT
Comparisons between groups undergoing MRI and CT
are listed in Table 1. A total of 158 scans (103 CT and
55 MRI) were reviewed by the study neuroradiologist.
Patients referred for MRI were younger and more likely
to have hypertension (defined as a history of hyperten¬
sion or a blood pressure reading of > 160/95 mm Hg at
the time of the examination) than patients who under¬
went CT. The percentage of patients with at least one le¬
sion, as well as the mean number of lesions, was signifi¬
cantly higher in the MRI group. Because of the different
demographic characteristics of patients referred for MRI
vs CT, as well as the difference in the frequency of le¬
sions seen using the two techniques, scan type (MRI or
CT) was used as a between-group factor in the ANOVA.
In addition, the percentage of patients with "caps" was
markedly increased in the MRI group. Education and du¬
ration of AD were similar in the MRI and CT groups, as
were the measures of disease severity: the mMMSE and
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than one image on CT were grounds for exclusion for the
same reason.
Lesions were categorized by location: in the centrum
semiovale, corpus callosum, internal capsule, basal ganglia,
thalamus, midbrain, pons, cerebellum, or subcortical white
matter. The number of lesions was rated similarly on CT or
MRI as follows: none, single (£3 mm but s2 cm), few (less
than five or less than two confluent), multiple (five or more
or two or more confluent), or diffuse (many confluent).
Periventricular caps, defined as areas of hypodensity
on CT scans or high-signal intensity on T2-weighted MRIs
at the poles of the ventricles, were rated as present or ab¬
sent. These were distinguished from periventricular "ha¬
los," which were defined as smooth lines of increased sig¬
nal on MRIs at the periventricular margin. Periventricular
white matter lesions were confined to the area surround¬
ing the ventricles. Subcortical was defined as the white mat¬
ter directly beneath the cortex, but not extending to the
ventricles. These definitions were patterned after the neu-
roimaging protocol of the Consortium to Establish a Reg¬
istry for Alzheimer's Disease.8
CORRELATION OF RADIOGRAPHIC FINDINGS
WITH OTHER MEASURES OF DISEASE SEVERITY
For this analysis, specific disease severity measures exam¬
ined included a measure of intellectual function (the
mMMSE), a measure of functional capacity (the Blessed De¬
mentia Rating Scale (Part I) (BDRS-I),9 and a measure of
vascular risk factors (the Hachinski Ischemie Scale).10
The mMMSE is a 57-item test of intellectual func¬
tion. Based on the Folstein MMSE,7 it includes additional
items to test digit span, attention/calculation, general knowl¬
edge, language, and construction.
The BDRS-I served as a measure of functional impair¬
ment and allowed measurement of cognitive impairment,
personality change, apathy, or basic self care. The Infor-
mation Memory Concentration portion of the BDRS-I was
not included. The identified caregiver provided responses
to the BDRS-I items in all instances. Only the total score of
the BDRS-I was examined in this analysis.
STATISTICAL ANALYSIS
To answer the question of whether the presence of lesions
contributed to disease severity in AD (defined as perfor¬
mance on the mMMSE and the BDRS-I), three sets ofanaly¬
ses were performed. First, because no attempt was made
to standardize the type of imaging study patients received,
we contrasted the patients who had CT with those who had
MRI. Student t tests for independent samples and  2 tests
were used to examine group means and proportions, re¬
spectively.
Second, disease severity measures were subjected to
two-way analysis of variance (ANOVA) with scan type (MRI
vs CT) and lesion number as between-group factors. Scan
type was included as a between-group factor because there
were important differences in age, in the presence of hy¬
pertension, and lesion frequency between patients with CT
and patients with MRI. Subjects were divided into three
groups based on the number of lesions on CT or MRI, and
this lesion group variable was included in the ANOVA. The
three lesion groups were (1) no lesions, (2) single (S3 mm
but £2 cm) or few (fewer than five or fewer than two con¬
fluent), and (3) multiple (more than five or more than two
confluent) or diffuse (many confluent). Covariates were age
and disease duration. A similar analysis was performed sub¬
stituting the presence or absence of periventricular caps for
lesion group.
Third, the mMMSE was considered as a dependent vari¬
able, while age, disease duration, hypertension, and lesion
number were independent variables in a multiple regres¬
sion. A similar analysis was performed with periventricu¬
lar caps replacing lesion number in the regression model.
the BDRS-I scores. There was no difference in Hachin¬
ski Ischemie scores between the two groups.
LOCATION OF LESIONS
Patients with white matter lesions as well as lesions in
the deep gray matter (basal ganglia and thalamus) were
included, as long as they met the radiologie study crite¬
ria. Overall, 15 patients had lesions in the basal ganglia:
five had two or more. Three patients had a single tha-
lamic lesion. Sixty-five patients had subcortical lesions:
31 had two or more. Twenty-three patients had periven¬
tricular lesions: 22 had two or more. Twenty-four pa¬
tients had lesions in more than one region (basal gan¬
glia, thalamic, subcortical, or periventricular).
There was no relationship between lesion number
and focal atrophy detected in cortical, frontal, sylvian fis¬
sure, temporal sulci, temporal horns, parietal, occipital,
brain-stem, or cerebellar regions.
When patients were categorized by lesion group(Table %), no difference was seen among groups in
age, education, duration of AD, or systolic BP. The dis¬
ease severity measures—the mMMSE and the BDRS-I
scores—were similar, as was the Hachinski Ischemie
Scale score. A significantly higher percentage of peri¬
ventricular caps were seen in the patients in the lesion
group with multiple or diffuse lesions (group 3).
Patients with periventricular caps were signifi¬
cantly older than those without caps, although disease
duration did not differ. The Hachinski Ischemie score
was elevated in those with periventricular caps, and
the mean lesion number was markedly higher. Despite
these differences, the mMMSE and BDRS-I scores were
similar in those with and without periventricular caps(Table 3).
When the measures of disease severity—the mMMSE
and the BDRS-I scores—were subjected to two-way
ANOVA with scan type and lesion group as between-
group factors and age and disease duration as covari¬
ates, no relationship was seen between lesion number and
disease severity. When the presence or absence of peri¬
ventricular caps was substituted for lesion group in the
same two-way ANOVA, again no between-group effect
was seen in the mMMSE or BDRS-I scores.
Lastly, the mMMSE score was considered as a de¬
pendent variable, with lesion number, age, duration of
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Table 1. Demographics of Patients With
Magnetic Resonance Imaging (MRI)
and Computed Tomography (CT);
Mean (SD)
MRI CT(n=55) (n=103)
Age, y 70.5 (8.9) 75.0 (8.0)t
Duration, y 3.8 (2.2) 3.9 (2.4)
Education, y 13.5(4.2) 12.9(3.4)
% with hypertension 53.2 28.0J
% with lesions 67.3 49.5
Mean No. of lesions 5.7 (7.8) 1.8 (2.6)t
% with caps 70.9 32.0J
mMMSE 38.1 (5.2) 37.6 (3.7)
BDRS-I 8.2 (3.8) 8.0 (3.4)
* mMMSE indicates Modified Mini-Mental State examination; BDRS-I,
Blessed Dementia Rating Scale (Part I).
tP<.flí.
Table 2. Characteristics of Patients in Each Lesion Group*
Mean (SD)
 -1
No Lesions 5 Lesions 5 Lesions
_
(n=70) (n=69) (n=19)
Age, y 71.8(8.5) 74.8(8.3) 74.4(9.6)
Education, y 13.4(3.4) 12.7(4.0) 13.0(4.2)
Duration, y 4.0(2.5) 3.8(2.3) 3.6(1.6)
mMMSE 37.9 (5.2) 38.2 (6.2) 36.1 (3.9)
BDRS-I 8.3(3.7) 7.7(3.3) 8.7(3.9)
Hachinski
Ischemie 1.4(1.1) 1.5(1.2) 1.7(2.3)
% with caps 27.0 54.0 84.0f
* mMMSE indicates Modified Mini-Mental State examination; BDRS-I,
Blessed Dementia Rating Scale (Part I).
fP<. 001.
Table 3. Demographic Characteristics of Patients
With and Without Caps*
Mean (SD)
i- I
Without Caps With Caps(n=86)_(n=72)
Age, y 71.7(8.5) 75.4 (8.4)t
Duration, y 3.9 (2.3) 3.8 (2.4)
mMMSE 38.2 (5.7) 37.3 (5.4)
BDRS-I 7.7 (3.6) 8.4 (3.5)
Hachinski Ischemie 1.2(1.1) 1.8(1.1)1
Mean No. of lesions 1.6 (2.8) 5.0 (6.9)t
* mMMSE indicates Modified Mini-Mental State examination; BDRS-I,
Blessed Dementia Rating Scale (Part I).jP<.001.
t?<.05.
AD, and presence of hypertension as independent vari¬
ables in a regression analysis. Only duration of illness was
correlated with worsening performance on the mMMSE(F=4.96). In an identical regression with presence of peri¬
ventricular caps substituted for lesion number, again only
duration of illness was inversely correlated with the
mMMSE score.
RELATIONSHIP BETWEEN RADIOGRAPIC
FINDINGS AND PATHOLOGIC FINDINGS
Ten patients who were enrolled in the study have come
to autopsy. Of eight patients who had no evidence of le¬
sions or periventricular caps on the scans performed be¬
fore study entry, four had no pathologic correlates of in¬
farction. Two patients had evidence of acute infarction.
Two patients had evidence of old infarcts: one, whose scan
was performed 2 years prior to death, had a 2X2- cm in¬
farcì in the right occipital lobe; the other, whose scan was
performed 4 years prior to death, had a stroke 3 months
prior to death and had a radiologically correlated lesion
in the right parietal lobe. Two patients had evidence of
both subcortical lesions and caps, one on MRI and one
on CT, yet no infarction was noted at autopsy in either
case.
COMMENT
In this group of 158 patients who met criteria for mild
to moderate AD and who had radiographie evidence of
periventricular white matter lesions or focal lesions
distinct from the ventricles but no historical or clinical
evidence of stroke, no differences could be found on a
measure of intellectual capacity, ie, the mMMSE, or on
a measure of functional capacity, ie, the BDRS-I.
The broad implications of this study are that this
subgroup of patients cannot be differentiated from
other patients with AD on the basis of the clinical
measures used. We recognize that we have narrowly
defined this subgroup. Clinical trials rigorously define
inclusion and exclusion criteria for participation in
experimental treatment for AD. Because patients with
this clinical profile and with such imaging findings are
commonly seen, we believe that they should not be
excluded from clinical trials. All subjects met the crite¬
ria of the Diagnostic and Statistical Manual of Mental
Disorders, Revised Third Edition, for AD and would
have been accepted for most clinical trials had they
not had radiographie abnormalities.
This is a cross-sectional analysis, which cannot elimi¬
nate differences in patterns of progression in patients with
and without lesions. Nevertheless, this study has numer¬
ous strengths, including a large sample size, careful sample
selection, good test-retest reliability for the neuroimag-
ing, and no question about interrater reliability, be¬
cause only one neuroradiologist reviewed all scans us¬
ing a systematic protocol.
A number of studies have addressed the clinical im¬
port of white matter lesions in clinically normal elderly
subjects12'14 and more recently in patients with AD.15 Our
study is unique because patients had no symptoms or signs
of stroke and the lesions were discovered incidentally dur¬
ing the imaging portion of the dementia evaluation. We
included patients with small lesions in the deep gray mat¬
ter (basal ganglia and thalamus) as well as in the white
matter.
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WHITE MATTER LESIONS
IN NORMAL ELDERLY SUBJECTS
Whether white matter lesions have an independent con¬
tribution to cognitive or functional impairment in AD is
difficult to assess from the available literature. White mat¬
ter lesions are common in nondemented as well as de¬
mented elderly subjects.1617 Unless there are more le¬
sions or strategically placed lesions in the demented
subjects, then such lesions alone cannot account for cog¬
nitive impairment. Lesions may be a confounder for other
factors associated with cognitive impairment. In a study
of hypertensive and nonhypertensive individuals,18 high-
signal punctate lesions were found in 38% of the hyper¬
tensive group and 20% of the controls. Although the hy¬
pertensive group performed significantly worse than the
control group on memory and learning tasks, no differ¬
ence was seen within the hypertensive group between
those with and without lesions, suggesting that cogni¬
tive impairment might be mediated by nonstructural in¬
fluences associated with hypertension.
DEFINITION OF LEUKOARAIOSIS
Leukoaraiosis on CT has been associated with cognitive
impairment in AD,17 while leukoaraiosis araiosis on MRI
has not.1519 Leukoaraiosis was defined by Hachinski et
al4 as "diminution of the density of representation of the
white matter." If leukoaraiosis depicted by CT and MRI
are etiologically similar, why is there a discrepancy be¬
tween the MRI and CT studies? It may be, as suggested
by Hachinski and colleagues,4 that the pathology of the
periventricular white matter changes seen on MRI is dif¬
ferent from the irregular white matter hypointensity seen
on CT that is termed leukoaraiosis. The use of the term
leukoaraiosis to represent findings on CT or MRI that may
be both periventricular and deep may explain the dis¬
crepant findings in the literature.
In a study of interobserver variation in CT con¬
ducted at the University ofWestern Ontario, London, leu¬
koaraiosis was defined as areas of low density in the white
matter that are ill defined, focal or confluent, and found
in a periventricular or deep white matter position.20 In
addition to the periventricular hyperintense regions on
MRI, incidental white matter signal hyperintensity can
be identified on MRI in both healthy control sub¬jects2122 and patients with AD.23 In fact, leukoaraiosis on
CT correlated strongly with focal white matter signal hy¬
perintensity on MRI, but not with periventricular dif¬
fuse changes.19 Leukoaraiosis on MRI may represent in¬
farction, gliosis, or demyelination.24 26 The increased
sensitivity of MRI may render some relationships seen
consistently on CT less meaningful. The findings on MRI
studies may be difficult to interpret, as noted by the fair
to good interobserver reliability for two observers rat¬
ing periventricular hyperintensities ( =0.43) and other
white matter hyperintensities ( =0.50) in 42 subjects with
AD.15
In their report on criteria for the definition of is¬
chemie vascular dementia, Chui et al27 suggested that T2-
weighted MRIs not be used for the assessment of infarct
size or number because of the possibility that white mat-
ter lesions of unknown significance might be detected
and lead to an overestimate of the prevalence of vascu¬
lar dementia.27
WHITE MATTER CHANGES IN AD
With CT, attempts have been made to determine whether
periventricular white matter hypodensity or hypoattenu-
ation in patients with AD is associated with specific cog¬
nitive or psychiatric features. In a study by Lopez et al,28
CT evidence of periventricular hypodensity was not as¬
sociated either with specific cognitive deficits measured
by a comprehensive, 15-test neuropsychological battery
or with progression of AD over 1 year. Patients with peri¬
ventricular hypodensity did have higher Hachinski Is¬
chemie rating scores and were more likely to develop dis¬
ease during follow-up. Diaz et al,29 using a shorter
neuropsychological evaluation, the Extended Scale for
Dementia, found that leukoaraiosis, defined on CT as fo¬
cal or confluent, was associated, along with disease du¬
ration, with a greater degree of cognitive impairment, al¬
though it accounted for only 11.6% of the variance.
Magnetic resonance imaging has also been used to
examine white matter lesions in patients with AD. Leys
et al15 found no difference between patients with AD and
controls without vascular risk factors in the severity of
white matter hyperintensities or periventricular hyper¬
intensities on MRI. Morris et al,30 in a longitudinal study
of 39 patients over 66 months, found no significant dif¬
ferences in dementia severity or mortality in patients with
or without periventricular white matter lesions on MRI.
Our sample, though clearly not representative of all
patients with AD, was selected on the basis of the pres¬
ence of relatively mild cognitive impairment. There were
no focal neurologic deficits at entry. In this analysis, we
focused only on the presence of deep gray matter or white
matter signal hyperintensity on MRIs or on deep gray mat¬
ter or white matter hypodensity on CT scans and peri¬
ventricular caps defined as areas of hypodensity on CT
scans or increased signal on T2-weighted MRIs at the poles
of the ventricles. We did not consider diffuse, symmet¬
ric signal hyperintensity. Because of the known associa¬
tions among white matter lesions, age, and hyperten¬
sion, these were controlled for in the analysis, along with
disease duration. Although our cognitive evaluation was
not extensive, we believe that in this strictly defined group
of patients without clinical evidence of stroke, focal white
matter lesions do not contribute to the cognitive impair¬
ment and should not preclude a diagnosis of probable
AD. Our preliminary review of the autopsy data do not
suggest infarction as an explanation for the radio-
graphic abnormalites detected. Evidence that increased
signal in the white matter on T2-weighted MRI studies
is pathologically correlated with spongiosis if extensive
and with dilated Virchow-Robin spaces if punctate,31
rather than with infarction, lends further credence to in¬
cluding these patients among those with probable AD.
Longitudinal follow-up of these patients will provide in¬
formation on disease progression and differential mor¬
tality in these subjects, and may ultimately further elu¬
cidate the pathologic correlates for the white matter
abnormalities commonly seen.
Downloaded From: http://archneur.jamanetwork.com/pdfaccess.ashx?url=/data/journals/neur/16362/ by a Columbia University User  on 06/13/2017
Accepted for publication November 9, 1993.
This study was supported in part by federal grants
AG07232, AG07370, MOI RR00645, and NIA R35-
AG10963 and by the Charles S. Robertson Gift for Alz¬
heimer's Disease.
Reprint requests to Neurological Institute, 710 W 168th
St, Box 5, New York, NY 10032 (Dr Marder).
REFERENCES
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental
Disorders, Revised Third Edition. Washington, DC: American Psychiatric As-
sociation; 1987.
2. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clini-
cal diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group
under the auspices of the Dept. of Health and Human Services Task Force on
Alzheimer's Disease. Neurology. 1984;34:939-944.
3. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type:
a pathoanatomical study. Ann Neurol. 1986;19:253-262.
4. Hachinski V, Potter P, Mersky H. Leuko-araiosis. Arch Neurol. 1987;44:21-23.
5. Stern Y. Folstein M, ALbert M, et al. Multi-center study of predictors of dis-
ease course in Alzheimer's disease (the 'Predictors Study'), I: study design,
cohort description and intersite comparisons. Alzheimer Dis Assoc Dis. 1993;
7:3-21.
6. Stern Y, Sano M, Paulson J, Mayeux R. Modified Mini-Mental State examina-
tion: validity and reliability. Neurology. 1987;37(suppl 1):179. Abstract.
7. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method
for grading the cognitive state of patients for the clinician. J Psychiatr Res.
1975;12:189-198.
8. Davis PC, Gray L, Albert M, et al. The Consortium to Establish a Registry for
Alzheimer's Disease (CERAD), III: reliability of a standardized MRI evaluation
of Alzheimer's disease. Neurology. 1992;42:1676-1680.
9. Blessed G, Tomlinson BE, Roth M. The association between quantitative mea-
sures of dementia and of senile changes in the cerebral grey matter of elderly
subjects. Br J Psychol. 1968;225:797-811.
10. Hachinski VC, lliff LD, Zhilka E, et al. Cerebral blood flow in dementia. Arch
Neurol. 1975;32:632-637.
11. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York,
NY: John Wiley & Sons Inc; 1981.
12. Kobari M, Meyer JS, Ichijo M. Leuko-araiosis, cerebral atrophy, and cerebral
perfusion in normal aging. Arch Neurol. 1990;47:161-165.
13. Rezek DL, Morris JC, Fulling KH, Gado MH. Periventricular white matter lu-
cencies in senile dementia of the Alzheimer's type and in normal aging. Neu-
rology. 1987;37:1365-1368.
14. Hendrie H, Farlow M, Austrom M, Edwards M, Williams M. Foci of T2 signal
intensity on brain MR scans of healthy elderly subjects. AJNR Am J Neuro-
radiol. 1989;10:703-707.
15. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo J, Steinling M. Periventricular
and white matter magnetic resonance imaging hyperintensities do not differ
between Alzheimer's disease and normal aging. Arch Neurol. 1990;47:524\x=req-\
527.
16. Steingart A, Hachinski V, Lau C, et al. Cognitive and neurologic findings in
subjects with diffuse white matter lucencies on computed tomographic scan
(leuko-araiosis). Arch Neurol. 1987;44:32-35.
17. Steingart A, Hachinski C, Lau C, et al. Cognitive and neurologic findings in
demented patients with diffuse white matter lucencies on computed tomo-
graphic scan (leuko-araiosis). Arch Neurol. 1987;44:36-39.
18. Schmidt R, Fazekas F, Offenbacher H, et al. Magnetic resonance imaging white
matter lesions and cognitive impairment in hypertensive individuals. Arch Neu-
rol. 1991;48:417-420.
19. Mirsen T, Lee D, Wong C, et al. Clinical correlates of white-matter changes on
magnetic resonance imaging scans of the brain. Arch Neurol. 1991;48:1015\x=req-\
1021.
20. Lee D, Fox A, Vinuela F, et al. Interobserver variation in computed tomography
of the brain. Arch Neurol. 1987;44:30-31.
21. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical le-
sions identified on magnetic resonance imaging in the elderly, I: correlation
with age and cerebrovascular risk factors. Stroke. 1986;17:1084-1089.
22. Fazekas F, Nierderkorn K, Schmidt R, et al. White matter signal abnormalities
in normal individuals: correlation with carotid ultrasonography, cerebral blood
flow measurements and cerebrovascular risk factors. Stroke. 1988;19:1285\x=req-\
1288.
23. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnor-
malities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neu-
roadiol. 1987;8:421-426.
24. Leifer D. Buonanno FS, Richardson EP Jr. Clinicopathologic correlations of
cranial magnetic resonance imaging of periventricular white matter. Neurol-
ogy. 1990;40:911-918.
25. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer
WW. Brain MR: pathologic correlation with gross and histopathology, II: hy-
perintense white-matter foci in the elderly. AJNR Am J Neuroradiol. 1988;9:
629-636.
26. Marshall VG, Bradley WG, Marshall CE, Bhoopat T, Rhodes RH. Deep white
matter infarction: correlation of MR imaging and histopathologic findings. Ra-
diology. 1988;167:517-522.
27. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria
for the diagnosis of ischemic vascular dementia proposed by the state of Cali-
fornia Alzheimer's disease diagnostic and treatment centers. Neurology. 1992;
42:473-480.
28. Lopez 0, Becker J, Rezek D, et al. Neuropsychiatric correlates of cerebral white-
matter radiolucencies in probable Alzheimer's disease. Arch Neurol. 1992;49:
828-834.
29. Diaz JF, Merskey H, Hachinski V, et al. Improved recognition of leuko-araiosis
and cognitive impairment in Alzheimer's disease. Arch Neurol. 1991 ;48:1022\x=req-\
1025.
30. Morris JC, Gado MH, Grant EA, Rezek DL. Periventricular white matter lucen-
cies: no effect on the natural history of senile dementia of Alzheimer's type.
Ann Neurol. 1988;24:159-160.
31. Munoz D, Hastak S, Harper B, Lee D, Hachinski V. Pathologic correlates of
increased signals of the centrum ovale on magnetic resonance imaging. Arch
Neurol. 1993;50:492-497.
Downloaded From: http://archneur.jamanetwork.com/pdfaccess.ashx?url=/data/journals/neur/16362/ by a Columbia University User  on 06/13/2017
